別名:   3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide 3-甲基-4-氧代-8-咪唑并[5,1-d][1,2,3,5]四嗪甲酰胺 4-甲基-5-氧代-2,3,4,6,8-五氮雜雙環(huán)[4.3.0]壬基-2,7,9-三烯-9-甲酰胺 8-氨甲酰-3-甲基咪唑[5,1-d]-1,2,3,5-四嗪-4(3H)-酮 NSC 362856

• 經(jīng)驗(yàn)分子式（希爾表示法）  C₆H₆N₆O₂

• 分子量  194.15

•  MDL number  MFCD00866492

產(chǎn)品名稱

Frequently Asked Questions

Frequently Asked Questions are available for this Product.

包裝

25, 100 mg in glass bottle

Preparation Note

Temozolomide is soluble in DMSO at a concentration that is greater than 20 mg/ml. It is insoluble in water.

Application

Temozolomide has been used for analyzing drug resistance mechanisms in glioblastoma cell lines^15,16.

Biochem/physiol Actions

Temozolomide is a DNA methylating agent and drug resistance-modifying agent; anti-tumor and anti-angiogenic. Temozolomide induces G2/M arrest and apoptosis through adduction of a methyl group to O6 position of guanine in genomic DNA and functional inactivation of DNA repair protein O(6)-alkylguanine DNA alkyltransferase (AGT) in base excision repair (BER) pathway.

Features and Benefits

This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

性質(zhì)